ASH 2016: Ruben Mesa, MD, Discusses Key MPD Updates at This Year’s Meeting

Dr. Mesa pinpoints some of the exciting news coming out of the 2016 ASH annual meeting in the area of myeloproliferative disorders. He discusses new data on interferon, ruxolitinib, pacritinib and momelotinib.